Market LIVE
Published markets; coverage varies by country
Product profile · United States

ZILXI

 ·  Patent Litigation & Settlement History ↓

IngredientMINOCYCLINE HYDROCHLORIDE
Application typeNDA
Application213690
Product001
Dosage formAEROSOL, FOAM
RouteTOPICAL
StrengthEQ 1.5% BASE
Approval date2020-05-28
Marketing statusPrescription
Status event—
ApplicantJOURNEY
Product source

Current GenericRadar decision

Year2030
SelectionCANDIDATE
ReviewFINAL_CHECKING
Anchor typeDS_EQUIVALENT
Anchor date2030-10-01
Patent anchor2030-10-01
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

GNR judgment: CANDIDATE. Reference year: 2030. Anchor type: DS_EQUIVALENT. Patent anchor: 2030-10-01. Exclusivity anchor: not recorded. Anchor date: 2030-10-01. Patent tail: no. Exclusivity tail: no. Review status: FINAL_CHECKING. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
102135122030-10-01DP/U U-1631———
———
102654042030-10-01DP ————
———
103221862030-10-01U U-1631———
———
109461012030-10-01U U-1631———
———
121383112030-10-01U U-1631———
———
126614072030-10-01U U-1631———
———
88651392030-10-01DP/U U-1631———
———
89455162030-10-01DP ————
———
89928962030-10-01DP/U U-1631———
———
96757002030-10-01DP/U U-1631———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 1 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Challenger / ANDAEventLawsuit filedDismissalAnnouncementSettlement entryApprovalEvidence
Padagis / 217148 PARAGRAPH_IV 2022-05-02 2022-05-19 2022-05-24 2027-04-01 NOT_ESTABLISHED SOURCE_DOCUMENTED
P4 challenge documented by complaint; challenge/certification submission date not verified. Lawsuit and settlement are separate legal milestones. No final FDA approval inferred.
Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

Event datePartyEvent Licensed entryEvidenceSource
2022-05-24 Padagis SETTLEMENT 2027-04-01 REVIEW —
Brand-specific license; confirm original manufacturer release